Paper Details

  1. Home
  2. Paper Details

Clinical Care Team's Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report.

Author: El DemerdashDoaa Mohamed, ElgendyMarwa O, HamedEman Mostafa, IbrahimAhmed R N, KhalafAhmed M, MahmoudTamer M, MeabedMohamed Hussein, RabeaHoda, SaeedHaitham, SalemHeba F

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

This case report describes a patient who experienced acute kidney injury during Eltrombopag therapy for immune thrombocytopenia (ITP). This highlights the importance of vigilant kidney function screening in patients receiving Eltrombopag.
Paper Details　
Original Abstract of the Article :
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder caused by antigen-specific T cells and antiplatelet autoantibodies that inhibit platelet production in the bone marrow or destroy platelets in the spleen. ITP is a form of autoimmunity and is closely associated with inflammation. Corti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536306/

データ提供：米国国立医学図書館（NLM）

Eltrombopag: A Double-Edged Sword in Immune Thrombocytopenia Treatment

Immune thrombocytopenia (ITP) is a complex autoimmune disorder that can lead to severe bleeding complications. Eltrombopag, a thrombopoietin receptor agonist, is often used to treat ITP. This study presents a case report highlighting a potential complication associated with Eltrombopag therapy: acute kidney injury. The case study emphasizes the importance of vigilant monitoring and prompt action to manage this potential side effect.

Eltrombopag: Balancing Benefits and Risks

The case report highlights the need for careful monitoring of kidney function in patients receiving Eltrombopag therapy. The development of acute kidney injury underscores the importance of balancing the benefits of Eltrombopag with the potential risks.

Navigating ITP Treatment: A Balancing Act of Benefits and Risks

This case study reinforces the importance of personalized medicine and the need for comprehensive assessment of individual risks and benefits when choosing treatment options for ITP. The development of acute kidney injury during Eltrombopag therapy emphasizes the need for vigilance and prompt intervention when necessary.

Dr. Camel's Conclusion

The treatment of ITP can be a journey through a complex desert, with both potential benefits and risks. This case report serves as a reminder to approach Eltrombopag therapy with caution and vigilance, recognizing the possibility of acute kidney injury as a potential complication.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-10-03
Further Info :

Pubmed ID

37763764

DOI: Digital Object Identifier

PMC10536306

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.